Study Stopped
Terminated by sponsor before enrolling any patients into the study.
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
The VITALITY Registry
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The purpose of this registry study is to learn more about metabolic health. The information gathered will be used to support research on the natural history of obesity and weight related diseases, their treatments, and how it affects overall health. Approximately 15,000 participants who are overweight or have obesity with or without metabolic diseases are expected to participate in this registry study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 3, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedApril 9, 2024
March 1, 2023
Same day
April 3, 2024
April 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Main Objective of Registry
The main objective of the registry is real-world evidence reflecting the experience of individuals in regards to their metabolic health.
Up to 10 years
Interventions
Once-weekly subcutaneous injectable
Once-weekly subcutaneous injectable
Eligibility Criteria
This is a prospective, observational registry to study metabolic health in individuals.
You may qualify if:
- At least 18 years of age (or age of majority)
- Willing to provide consent to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CorEvitaslead
- Eli Lilly and Companycollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2024
First Posted
April 9, 2024
Study Start
July 1, 2023
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
April 9, 2024
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share